Conroy Kevin T. - 25 Feb 2026 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
25 Feb 2026
Net transactions value
-$640,976
Form type
4
Filing time
27 Feb 2026, 16:30:25 UTC
Previous filing
30 Dec 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Conroy Kevin T President and CEO, Director C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON /s/ Kevin T. Conroy by Mark Busch, attorney-in- fact 27 Feb 2026 0001306119

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $0 +13,181 +1.1% $0.000000 1,248,151 25 Feb 2026 Direct F1
transaction EXAS Common Stock Tax liability $640,976 -6,196 -0.5% $103.45 1,241,955 25 Feb 2026 Direct F2, F3
holding EXAS Common Stock 29,051 25 Feb 2026 Held in 401(k) Plan
holding EXAS Common Stock 46,538 25 Feb 2026 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 86,750 25 Feb 2026 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 117,427 25 Feb 2026 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Award $0 +154,829 $0.000000 154,829 25 Feb 2026 Common Stock 154,829 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by the Issuer for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 1,521,721 shares, Mr. Conroy also holds, in the aggregate, an additional 805,226 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 These restricted stock units vest in four equal annual installments beginning on February 25, 2027.